Log in to save to my catalogue

Is there a Future for CYP1A2 Pharmacogenetics in the Optimal Dosing of Clozapine?

Is there a Future for CYP1A2 Pharmacogenetics in the Optimal Dosing of Clozapine?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2403756019

Is there a Future for CYP1A2 Pharmacogenetics in the Optimal Dosing of Clozapine?

About this item

Full title

Is there a Future for CYP1A2 Pharmacogenetics in the Optimal Dosing of Clozapine?

Author / Creator

Publisher

England: Future Medicine Ltd

Journal title

Pharmacogenomics, 2020-04, Vol.21 (6), p.369-373

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

The polycyclic aromatic hydrocarbons present in tobacco smoke bind to a nuclear receptor called the aryl hydrocarbon receptor which induces CYP1A2 expression. Geriatric age, which is associated with decreased renal function, probably decreases the clearance of NCLO and other hydrophilic metabolites (2). Zanger and Schwab also suggested that other u...

Alternative Titles

Full title

Is there a Future for CYP1A2 Pharmacogenetics in the Optimal Dosing of Clozapine?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2403756019

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2403756019

Other Identifiers

ISSN

1462-2416

E-ISSN

1744-8042

DOI

10.2217/pgs-2020-0015

How to access this item